Literature DB >> 8810328

Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene.

H Kotanides1, N C Reich.   

Abstract

This study addresses the function of STAT6 in interleukin-4-stimulated gene expression. A specific STAT6 DNA-binding target site has been identified in the promoter of the interleukin-4 receptor gene, and STAT6 is shown to be involved in mediating activation of gene expression via this site. STAT6 can mediate transcription of a heterologous reporter gene construct containing the interleukin-4 receptor STAT6 binding site. In addition, evidence is provided that demonstrates a distinct effect of STAT6 DNA binding specificity on transcriptional regulation since transcription was not stimulated from a competent but different DNA binding site. To confirm the role of STAT6 in gene activation, STAT6 mutant proteins were generated and analyzed for their ability to function in interleukin-4-induced transcription. Although the interleukin-2 gamma chain receptor subunit has been demonstrated to be a component of the interleukin-4 receptor, it is not required for specific gene activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8810328     DOI: 10.1074/jbc.271.41.25555

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Histamine affects STAT6 phosphorylation via its effects on IL-4 secretion: role of H1 receptors in the regulation of IL-4 production.

Authors:  Geetanjali Kharmate; Zhongfeng Liu; Eric Patterson; Manzoor M Khan
Journal:  Int Immunopharmacol       Date:  2006-11-20       Impact factor: 4.932

Review 2.  IL-4: an important cytokine in determining the fate of T cells.

Authors:  J L Silva-Filho; C Caruso-Neves; A A S Pinheiro
Journal:  Biophys Rev       Date:  2014-01-09

3.  Serine protease inhibition attenuates rIL-12-induced GZMA activity and proinflammatory events by modulating the Th2 profile from estrogen-treated mice.

Authors:  Ebru Karpuzoglu; Chad W Schmiedt; Julian Pardo; Megan Hansen; Tai L Guo; Steven D Holladay; Robert M Gogal
Journal:  Endocrinology       Date:  2014-05-19       Impact factor: 4.736

4.  Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease.

Authors:  Erin E Olsan; Jonathan D West; Jacob A Torres; Nicholas Doerr; Thomas Weimbs
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-07

5.  Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching.

Authors:  M B Harris; C C Chang; M T Berton; N N Danial; J Zhang; D Kuehner; B H Ye; M Kvatyuk; P P Pandolfi; G Cattoretti; R Dalla-Favera; P B Rothman
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

6.  Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease.

Authors:  Erin E Olsan; Sambuddho Mukherjee; Beatrix Wulkersdorfer; Jonathan M Shillingford; Adrian J Giovannone; Gueorgui Todorov; Xuewen Song; York Pei; Thomas Weimbs
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

7.  Live cell imaging reveals continuous STAT6 nuclear trafficking.

Authors:  Hui-Chen Chen; Nancy C Reich
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

8.  Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression.

Authors:  H L Dickensheets; C Venkataraman; U Schindler; R P Donnelly
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 9.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

10.  PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling.

Authors:  Xiaoqing Lu; Raquel Malumbres; Benjamin Shields; Xiaoyu Jiang; Kristopher A Sarosiek; Yasodha Natkunam; Tony Tiganis; Izidore S Lossos
Journal:  Blood       Date:  2008-08-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.